KFDA mulls appealing court's ruling in bioequivalence testing data forged

Published: 2006-06-20 06:58:00

Updated: 2006-06-20 06:58:00

The Korea Food and Drug Administration (KFDA) said on June 15 that it is considering appealing the administrative court's ruling in favor of the generic makers in a dispute that a number of domestic bioresearch centers and pharmaceutical schools had been found to have fabricated test results of w...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK